Skip to content

Search

Montanna's diabetes dash

A diabetes diagnosis is a shock at any time but spare a thought for the Rustens who jumped on a plane to Perth from Kununurra within an hour of diagnosis.

Cholesterol and blood pressure drugs help teens with diabetes

Researchers from the Children’s Diabetes Centre have had a lead role in a global adolescent Type 1 Diabetes study.

Teenagers jump for a pump

Researchers from the Children's Diabetes Centre are currently conducting a group trial of the new and improved closed-loop insulin pump system.

Urgent device recall

Medtronic has issued an urgent medical device recall of their MiniMed infusion sets for potentially over-delivering insulin.

Have your say

The Children's Diabetes Centre values the importance of community members having a say by giving feedback and guidance on issues important to them.

T1D: Challenge accepted

One step at a time … that’s the message Canadian Sebastien Sasseville wants kids living with Type 1 Diabetes to know when he talks about his T1D journey.

A Long-Term Evaluation of Facebook for Recruitment and Retention in the ENDIA Type 1 Diabetes Pregnancy-Birth Cohort Study

The Environmental Determinants of Islet Autoimmunity (ENDIA) study is an Australia-wide pregnancy-birth cohort study following children who have a first-degree relative with type 1 diabetes (ACTRN1261300794707). A dedicated ENDIA Facebook page was established in 2013 with the aim of enhancing recruitment and supporting participant retention through dissemination of study information.

Mental Health During Late Pregnancy and Postpartum in Mothers With and Without Type 1 Diabetes: The ENDIA Study

Pregnancy and type 1 diabetes are each associated with increased anxiety and depression, but the combined impact on well-being is unresolved. We compared the mental health of women with and without type 1 diabetes during pregnancy and postpartum and examined the relationship between mental health and glycemic control.

Advances in Automated Insulin Delivery with the Medtronic 780G: The Australian Experience

To assess the real-world performance of MiniMed™ 780G for Australians with type 1 diabetes (T1D) following advanced hybrid closed loop (AHCL) activation and to evaluate the effect of changing from MiniMed 670/770G to 780G.